Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1

In recent years, studies have demonstrated that vascular endothelial growth factor B (VEGFB) can affect the metabolism of fatty acids and glucose, and it is expected to become a target for the diagnosis and treatment of metabolic diseases such as obesity and diabetes. At present, the specific mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xu, Li, Rong-Rong, Li, Yu-Qi, Yu, Han-Pu, Yu, Hai-Ning, Jiang, Wen-Guo, Li, Ya-Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366154/
https://www.ncbi.nlm.nih.gov/pubmed/35894135
http://dx.doi.org/10.3892/mmr.2022.12801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366154/
https://www.ncbi.nlm.nih.gov/pubmed/35894135
http://dx.doi.org/10.3892/mmr.2022.12801

Ejemplares similares